Katell Bidet Huang | Head of Translational Medicine
Transgene SA

Katell Bidet Huang is the head of Translational Medicine at Transgene, where she focuses on characterizing the immune responses after treatment with viral-vectored individualized cancer vaccine and oncolytic viruses. She has a scientific background in virology and immunology and a particular interest in understanding how and why patients respond to therapy. Prior to Transgene, she was head of Translational Research at Hookipa Pharma and Biomarker Scientist at Curevac. She obtained her PhD in molecular virology from the National University of Singapore and did her post-doctoral training at the Singapore-MIT Alliance for Research and Technology on dengue vaccine development.